The different way in which cancer cells metabolise sugar compared to normal cells is the focus of a clinical trial due to start early next year. [ + ]

Sample and assay technology company Qiagen has announced a collaboration agreement with Astellas Pharma to develop and commercialise companion diagnostics paired with Astellas drugs for use in cancer and other diseases. [ + ]

Further to the recent launch of the Industry Innovation and Competitiveness Agenda, the federal government has announced the establishment of an independent panel to undertake a review of medicines and medical devices regulation in Australia.

Antisense Therapeutics (ASX:ANP) has received positive feedback from the US FDA on plans to conduct an IND-enabling phase IIb trial of MS drug candidate ATL1102.

The US-based Seahorse Bioscience and Moffitt Cancer Center have received an SBIR contract, through the National Cancer Institute, to develop a reproducible method that will enable the measurement of metabolism of 3D microtissue. [ + ]

Law firm Morrison & Foerster (MoFo) has released its Q3 edition of BioMeter. The quarterly report measures the health of the biotech industry. [ + ]

The AusBiotech national conference will this week bring together the entire biotechnology 'ecosystem' to share ideas and progress their biotechnology development work.

Researchers from the Cornell University Food and Brand Lab have found that graphs or formulas accompanying medical information can lead consumers to believe products are more effective, despite not actually providing additional evidence. [ + ]

Researchers have disputed the claim that ancient Egyptian royal families suffered from the systemic disease ankylosing spondylitis, which causes inflammation of the spinal joints. [ + ]

ResMed (ASX:RMD) has reported its results for its fiscal first quarter and has unveiled new and improved patient management platforms for its sleep-disordered breathing treatment devices.

Alchemia (ASX:ACL) Chief Scientific Officer Dr Tracey Brown has won the Telstra Victorian Business Woman of the Year award and is now eligible to win the national award as well.

The annual Women in Nuclear (WiN) Global Award has been won by Dr Margaret Elcombe of the Australian Nuclear Science and Technology Organisation (ANSTO) - the first Australian ever to receive the award. [ + ]

The Medical Research Commercialisation Fund has granted $1m in financing to early-stage anti-infectives company Auspherix.

In a world first, the Australian Government has announced it will make 100 years of intellectual property (IP) rights data available online in order to make finding collaboration partners easier and allow the mapping of innovation.

The Australian Government has allocated $580.2 million to help Australian health and medical researchers find the cures, treatments and medical devices of the future. [ + ]